Class Action Trends in the Life Science Industry

April 24, 2014

For the last several years, the life sciences industry has been fertile ground for class action and aggregate litigation. Developments in this area have driven several trends with respect to state consumer fraud claims, securities class actions, antitrust class actions, and aggregate litigation brought by private healthcare insurers and state attorneys general.

Join us for a one-hour webinar, where we will discuss these trends as well as strategies for minimizing your litigation risk. Discussion topics will include:

  • Ramifications of the Class Action Fairness Act (CAFA)
  • Key types of class actions that life sciences companies are likely to encounter and the reasons why
  • Effects of increased consumer fraud actions brought by individuals as well as by health insurers and state attorneys general
  • Managing the risks associated with increased class action activity in the securities and antitrust arenas

Thomas J. Sullivan, Partner
R. Brendan Fee, Partner

CLE credit in FL, IL, NJ, NY, PA, TX, VA, and CA is currently pending approval.

For more information contact Domenica Curran at 415.442.1680 or dcurran@morganlewis.com